- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 2, 2025 | 14.31M sh |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $13.43M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $11.09M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $51.04M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $82.36M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $16.69M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $19.6M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $32.37M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $36.6M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $54.14M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $64.38M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $83.41M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $118.95M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 14.21M sh |
| Shares Diluted restated | Q2 2025 · Mar 31, 2024 | 14.19K sh |
| Capex | Q2 2025 · Mar 31, 2024 | $1.98M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $5.31M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.07 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.59 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.07 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.59 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $8.25M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $16.82M |
| Net Income | Q2 2025 · Mar 31, 2024 | $970K |
| Net Income | Q2 2025 · Mar 31, 2024 | −$8.39M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $1.36M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$7.57M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $8.45M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $16.67M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $16.98M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $32.83M |